Keep life-changing studies moving forward

Fragmented technology is one of the leading sources of site burden in clinical trials. According to Everest Group research sites manage an average of 22 sponsor-mandated systems within a single study, and 83% say technology burden increasingly influences their decision to participate in trials. Suvoda's unified platform addresses this directly: products share a single login, a common data layer, and consistent user experience design. For patients, the Suvoda App consolidates visit scheduling, questionnaires, payment status, travel support, and reminders in one place on a personal device, reducing the friction that contributes to dropout and non-compliance.

Suvoda's AI approach is grounded in a core principle: AI should accelerate and support human decision-making, not replace the human judgment that clinical trials require. Suvoda's AI capabilities operate within a validated knowledge space, enforce study-level permissions, and produce auditable outputs. Current AI deployments include Sofia, an AI assistant embedded in Suvoda RTSM and eCOA, and Agentic RTSM, which uses AI to automate and accelerate the study build and amendment process. Suvoda plans to extend agentic capabilities to eCOA and its financial services products.